Details of the Drug

General Information of Drug (ID: DMM6NKA)

Drug Name
TIPLASININ
Synonyms PAI-039; Tiplasinin < USAN; Tiplaxtinin (formerly); 2-[1-Benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl]-2-oxoacetic acid
Indication
Disease Entry ICD 11 Status REF
Thrombosis DB61-GB90 Discontinued in Phase 1 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C24H16F3NO4
Canonical SMILES
C1=CC=C(C=C1)CN2C=C(C3=C2C=CC(=C3)C4=CC=C(C=C4)OC(F)(F)F)C(=O)C(=O)O
InChI
InChI=1S/C24H16F3NO4/c25-24(26,27)32-18-9-6-16(7-10-18)17-8-11-21-19(12-17)20(22(29)23(30)31)14-28(21)13-15-4-2-1-3-5-15/h1-12,14H,13H2,(H,30,31)
InChIKey
ODXQFEWQSHNQNI-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
6450819
ChEBI ID
CHEMBL325441
CAS Number
393105-53-8
TTD ID
D02QBJ
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021321)